Cargando…
Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care
Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs a...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780732/ https://www.ncbi.nlm.nih.gov/pubmed/31547431 http://dx.doi.org/10.3390/jcm8091455 |
_version_ | 1783457206372401152 |
---|---|
author | Woodhouse, Braden Pattison, Sharon Segelov, Eva Singh, Simron Parker, Kate Kong, Grace Macdonald, William Wyld, David Meyer-Rochow, Goswin Pavlakis, Nick Conroy, Siobhan Gordon, Vallerie Koea, Jonathan Kramer, Nicole Michael, Michael Wakelin, Kate Asif, Tehmina Lo, Dorothy Price, Timothy Lawrence, Ben |
author_facet | Woodhouse, Braden Pattison, Sharon Segelov, Eva Singh, Simron Parker, Kate Kong, Grace Macdonald, William Wyld, David Meyer-Rochow, Goswin Pavlakis, Nick Conroy, Siobhan Gordon, Vallerie Koea, Jonathan Kramer, Nicole Michael, Michael Wakelin, Kate Asif, Tehmina Lo, Dorothy Price, Timothy Lawrence, Ben |
author_sort | Woodhouse, Braden |
collection | PubMed |
description | Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs and their heterogeneity makes QPI development difficult. CommNETs is a collaboration between NET clinicians, researchers and advocates in Canada, Australia and New Zealand. We created QPIs for NETs using a three-step consensus process. First, a multidisciplinary team used the nominal group technique to create candidates (n = 133) which were then curated into appropriateness statements (62 statements, 44 sub-statements). A two-stage modified RAND/UCLA Delphi consensus process was conducted: an online survey rated the statement appropriateness then the top-ranked statements (n = 20) were assessed in a face-to-face meeting. Finally, 10 QPIs met consensus criteria; documentation of primary site, proliferative index, differentiation, tumour board review, use of a structured pathology report, presence of distant metastasis, 5- and 10-year disease-free and overall survival. These NET QPIs will be trialed as a method to monitor and improve care for people with NETs and to facilitate international comparison. |
format | Online Article Text |
id | pubmed-6780732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67807322019-10-30 Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care Woodhouse, Braden Pattison, Sharon Segelov, Eva Singh, Simron Parker, Kate Kong, Grace Macdonald, William Wyld, David Meyer-Rochow, Goswin Pavlakis, Nick Conroy, Siobhan Gordon, Vallerie Koea, Jonathan Kramer, Nicole Michael, Michael Wakelin, Kate Asif, Tehmina Lo, Dorothy Price, Timothy Lawrence, Ben J Clin Med Article Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs and their heterogeneity makes QPI development difficult. CommNETs is a collaboration between NET clinicians, researchers and advocates in Canada, Australia and New Zealand. We created QPIs for NETs using a three-step consensus process. First, a multidisciplinary team used the nominal group technique to create candidates (n = 133) which were then curated into appropriateness statements (62 statements, 44 sub-statements). A two-stage modified RAND/UCLA Delphi consensus process was conducted: an online survey rated the statement appropriateness then the top-ranked statements (n = 20) were assessed in a face-to-face meeting. Finally, 10 QPIs met consensus criteria; documentation of primary site, proliferative index, differentiation, tumour board review, use of a structured pathology report, presence of distant metastasis, 5- and 10-year disease-free and overall survival. These NET QPIs will be trialed as a method to monitor and improve care for people with NETs and to facilitate international comparison. MDPI 2019-09-12 /pmc/articles/PMC6780732/ /pubmed/31547431 http://dx.doi.org/10.3390/jcm8091455 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Woodhouse, Braden Pattison, Sharon Segelov, Eva Singh, Simron Parker, Kate Kong, Grace Macdonald, William Wyld, David Meyer-Rochow, Goswin Pavlakis, Nick Conroy, Siobhan Gordon, Vallerie Koea, Jonathan Kramer, Nicole Michael, Michael Wakelin, Kate Asif, Tehmina Lo, Dorothy Price, Timothy Lawrence, Ben Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care |
title | Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care |
title_full | Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care |
title_fullStr | Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care |
title_full_unstemmed | Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care |
title_short | Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care |
title_sort | consensus-derived quality performance indicators for neuroendocrine tumour care |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780732/ https://www.ncbi.nlm.nih.gov/pubmed/31547431 http://dx.doi.org/10.3390/jcm8091455 |
work_keys_str_mv | AT woodhousebraden consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT pattisonsharon consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT segeloveva consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT singhsimron consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT parkerkate consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT konggrace consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT macdonaldwilliam consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT wylddavid consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT meyerrochowgoswin consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT pavlakisnick consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT conroysiobhan consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT gordonvallerie consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT koeajonathan consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT kramernicole consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT michaelmichael consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT wakelinkate consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT asiftehmina consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT lodorothy consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT pricetimothy consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT lawrenceben consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare AT consensusderivedqualityperformanceindicatorsforneuroendocrinetumourcare |